Verastem, Inc. (VSTM)

8.20 +0.22 (+2.76%) USD  |  NASDAQ  |  Sep 04, 16:00
8.10 -0.10 (-1.22%) After-Hours: 20:00
More

Verastem SG&A Expense (TTM) : 95.16M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for VSTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 95.16M
March 31, 2026 88.42M
December 31, 2025 81.14M
September 30, 2025 67.48M
June 30, 2025 58.75M
March 31, 2025 48.29M
December 31, 2024 43.62M
September 30, 2024 41.48M
June 30, 2024 36.57M
March 31, 2024 33.75M
December 31, 2023 30.73M
September 30, 2023 28.20M
June 30, 2023 27.26M
March 31, 2023 26.37M
December 31, 2022 24.98M
September 30, 2022 24.53M
June 30, 2022 23.63M
March 31, 2022 23.83M
December 31, 2021 24.12M
September 30, 2021 25.55M
June 30, 2021 40.64M
March 31, 2021 49.37M
December 31, 2020 62.76M
September 30, 2020 79.39M
June 30, 2020 80.93M
Date Value
March 31, 2020 94.78M
December 31, 2019 101.21M
September 30, 2019 103.68M
June 30, 2019 106.96M
March 31, 2019 93.47M
December 31, 2018 77.26M
September 30, 2018 57.86M
June 30, 2018 39.24M
March 31, 2018 27.85M
December 31, 2017 22.79M
September 30, 2017 20.90M
June 30, 2017 17.94M
March 31, 2017 17.73M
December 31, 2016 17.22M
September 30, 2016 16.59M
June 30, 2016 16.98M
March 31, 2016 17.18M
December 31, 2015 17.63M
September 30, 2015 17.67M
June 30, 2015 17.78M
March 31, 2015 18.15M
December 31, 2014 18.16M
September 30, 2014 17.44M
June 30, 2014 16.95M
March 31, 2014 16.41M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 620.29M
Dianthus Therapeutics, Inc. 44.15M
Alnylam Pharmaceuticals, Inc. 1.318B
Anika Therapeutics, Inc. 52.67M
Savara, Inc. 56.71M